¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"molecular layer, external"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
  • molecular weight
    ºÐÀÚ·®
  • molecular weight determination
    ºÐÀÚ·®ÃøÁ¤
  • automatic external defibrillator
    ¿ÜºÎÇüÀÚµ¿¼¼µ¿Á¦°Å±â
  • external
    ¹Ù±ù-, °Ñ, ¿Ü-
  • external acoustic meatus
    ¹Ù±ù±Í±æ, ¿ÜÀ̵µ
  • external acoustic pore
    ¹Ù±ù±Ó±¸¸Û, ¿ÜÀ̰ø
  • external appliance
    ¿ÜºÎÀåÄ¡
  • external auditory canal
    ¹Ù±ù±Í±æ, ¿ÜÀ̵µ
  • external auditory meatus reflex
    ¹Ù±ù±Í±æ¹Ý»ç, ¿ÜÀ̵µ¹Ý»ç
  • external callus
    ¹Ù±ù¾Ö¹ú»À, ¿Ü°¡°ñ
  • external canal cholesteatoma
    ¹Ù±ù±Í±æÁøÁÖÁ¾, ¿ÜÀ̵µÁøÁÖÁ¾
  • external capsule
    ¹Ù±ù¼¶À¯¸·, ¿ÜÆ÷
  • external cardiac massage
    ü¿Ü½ÉÀ帶»çÁö
  • external carotid artery
    ¹Ù±ù¸ñµ¿¸Æ, ¿Ü°æµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular spectrum
    ºÐÀÚ½ºÆåÆ®·³
  • molecular weight
    ºÐÀÚ·®
  • molecular air pump
    ºÐÀڽİø±âÆßÇÁ
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇа˻ç
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
  • molecular weight modifier
    ºÐÀÚ·®Á¶ÀýÁ¦
  • external appliance
    ¿ÜºÎÀåÄ¡
  • external carotid artery
    ¹Ù±ù¸ñµ¿¸Æ
  • external iliac artery
    ¹Ù±ù¾ûµ¢µ¿¸Æ
  • external pudendal artery
    ¹Ù±ùÀ½ºÎµ¿¸Æ
  • external rhinoplasty approach
    ¹Ù±ùÄÚ¼ºÇü¼úÁ¢±Ù¹ý
  • external callus
    ¿Ü°¡°ñ, ¹Ù±ù¾Ö¹ú»À
  • external capsule
    ¹Ù±ù¼¶À¯¸·
  • external auditory canal
    ¹Ù±ù±Í±æ, ¿ÜÀ̵µ
  • external canal cholesteatoma
    ¹Ù±ù±Í±æÁøÁÖÁ¾, ¿ÜÀ̵µÁøÁÖÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • adipose layer
    Áö¹æÃþ
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • anterior layer
    ¾ÕÃþ
  • arrangement of germinal layer
    Á¾ÀÚÃþ¹è¿­
  • functional layer
    ±â´ÉÃþ(ѦÒööµ).
  • functional layer of endometrium
    ÀڱüӸ·±â´ÉÃþ
  • fusiform layer
    ¹æÃß¼¼Æ÷Ãþ
  • ganglion cell layer
    ½Å°æÀý¼¼Æ÷Ãþ(¡­öµ).
  • ganglion cell layer
    ½Å°æÀý¼¼Æ÷Ãþ
  • ganglionic layer
    ½Å°æÀýÃþ(¡­öµ).
  • germ layer
    ¹è¿±(ÛÏç¨).
  • germinal layer
    ¹èÀÚÃþ, ¹è¾ÆÃþ(ÛÏä´öµ).
  • germinal layer
    Á¾ÀÚÃþ
  • germinative layer
    Á¾ÀÚÃþ, ¹è¾ÆÃþ(ÛÏä´öµ).
  • half value layer =HVL
    [¾È°ú]¹Ý°¡Ãþ(Úâʤöµ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • molecular clock
    ºÐÀÚ»ý¹°ÇÐÀû ½Ã°è
  • molecular colloid
    ºÐÀÚ(ÝÂí­)ÄÝ·ÎÀ̵å.
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°(ÝÂí­ ûùùêÚª).
  • molecular conductivity
    ¸ôÀüµµÀ² (¡­îîÓôëÒ).
  • molecular death
    ºÐÀÚ»ç(ÝÂí­ÞÝ).
  • molecular depression
    ºÐÀÚ°­ÇÏ(¡­Ë½ù»).
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»).
  • molecular dispersion
    ºÐÀںлê(¡­ÝÂߤ).
  • molecular distillation
    ºÐÀÚÁõ·ù(¡­ñúë§).
  • molecular elevation
    ºÐÀÚ»ó½Â(¡­ß¾ã°).
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö(¡­á¼ØþÌõâ¦).
  • molecular fat
    ºÐÀÚ¼º Áö¹æ(¡­àõò·Û¸).
  • molecular film
    ºÐÀÚ¸·(ÝÂí­Ø¯).
  • molecular filter
    ºÐÀڰŸ£°³.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • External acoustic meatus
    ¹Ù±ù±Í±æ [¿ÜÀ̵µ]
    [¿¾ ¿ë¾î] ¿ÜÀ̵µ
  • Nerve to external acoustic meatus
    ¹Ù±ù±Í±æ½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÀ̵µ½Å°æ
  • External acoustic pore
    ¹Ù±ù±Ó±¸¸Û
    [¿¾ ¿ë¾î] ¿ÜÀ̰ø
  • External lip
    ¹Ù±ù´É¼±
    [¿¾ ¿ë¾î] ¿Ü¼ø
  • External occipital protuberance
    ¹Ù±ùµÚÅë¼ö»ÀÀ¶±â
    [¿¾ ¿ë¾î] ¿ÜÈĵÎÀ¶±â
  • External coat
    ¹Ù±ù¸·
    [¿¾ ¿ë¾î] ¿Ü¸·
  • External surface
    ¹Ù±ù¸é
    [¿¾ ¿ë¾î] ¿Ü¸é
  • External carotid artery
    ¹Ù±ù¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] ¿Ü°æµ¿¸Æ
  • External carotid nerves
    ¹Ù±ù¸ñ½Å°æ
    [¿¾ ¿ë¾î] ¿Ü°æµ¿¸Æ½Å°æ
  • External carotid plexus
    ¹Ù±ù¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¿Ü°æµ¿¸Æ½Å°æÃÑ
  • External jugular vein
    ¹Ù±ù¸ñÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿Ü°æÁ¤¸Æ
  • External wall
    ¹Ù±ùº®
    [¿¾ ¿ë¾î] ¿Üº®
  • External part
    ¹Ù±ùºÎºÐ
    [¿¾ ¿ë¾î] ¿ÜÃøºÎ
  • External enamel epithelium
    ¹Ù±ù»ç±âÁú»óÇÇ
    [¿¾ ¿ë¾î] ¿Ü¿¡³ª¸á»óÇÇ
  • External mitochondrial membrane
    ¹Ù±ù»ç¸³Ã¼¸·
    [¿¾ ¿ë¾î] »ç¸³Ã¼¿Ü¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • molecular-exclusion chromatography
    ºÐÀÚ¹èÀç(ÝÂí­ÛÉð¶) Å©·Î¸¶ÅäÅ©·¡ÇÇ
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ(ÝÂí­ë¶îîùÊ)
  • molecular hybrid
    ºÐÀÚ(ÝÂí­) Æ¢±â
  • molecular mass
    ºÐÀÚÁú·®(ÝÂí­òõÕá)
  • molecular mimicry
    ºÐÀÚ ÀÇÅÂ(ÝÂí­ëô÷¾)
  • molecular orbital
    ºÐÀڱ˵µ(ÝÂí­ÏùÔ³)
  • molecular orbital theory
    ºÐÀڱ˵µ¼³(ÝÂí­ÏùÔ³àã)
  • molecular photosensitization
    ºÐÀÚ ±¤°¨ÀÛ(ÝÂí­ÎÃÊõíÂ)
  • molecular radioautography
    ºÐÀÚ ¹æ»ç¼±ÀÚ°¡±â·Ï¹ý(ÝÂí­Û¯ÞÒàÊí»Ê«ÑÀÖâÛö)
  • molecular rotation
    ºÐÀÚȸÀü(ÝÂí­üÞï®)
  • molecular sieve
    ºÐÀÚ(ÝÂí­)ä
  • molecular sieve chromatography
    ºÐÀÚ(ÝÂí­)ä Å©·Î¸¶Åä±×¶óÇÇ
  • molecular sieve coefficient
    ºÐÀÚ(ÝÂí­)ä °è¼ö(Ìõâ¦)
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • molecular taxonomy
    ºÐÀÚ ºÐ·ùÇÐ(ÝÂí­ÝÂ×¾ùÊ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ITLC instant thin-layer chromatography
LFL left frontolateral; leukocyte feeder layer; lower flammable limit
NFL nerve fiber layer; neurofilament protein, light polypeptide
NFLD nerve fiber layer defect
OPL other party liability; outer plexiform layer; ovine placental lactogen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
HPTLC High-performance thin-layer chromatographic
MLP Multi Layer Perceptron
NFL Nerve fiber layer
RNFL Retinal Nerve Fiber Layer
RNFL Retinal nerve fibre layer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular weight distribution
    ºÐÀÚ·® ºÐÆ÷
  • adipose layer
    Áö¹æ Ãþ
  • aponeurotic layer
    °Ç¸· Ãþ
  • basal epithelial layer
    ±âÀú »óÇÇ Ãþ
  • basal layer of endometrium
    ÀڱüӸ· ¹Ù´ÚÃþ
  • basal-cell layer
    ±âÀú ¼¼Æ÷Ãþ
  • Beilby layer
    ¹ÙÀϺñ Ãþ
    °íµµ·Î ¿¬¸¶µÈ ±Ý¼ÓÀÇ ¹«±¸Á¶Àû ºÐÀÚÀÇ Ç¥¸é Ãþ. °ÅÄ£ °ÍÀ» °¨¼Ò½Ã۱â À§ÇØ °è¼ÓÇØ¼­ ¿¬¸¶ÇØ ¾ò¾îÁø ºñ±³Àû ±ÜÈûÀÌ ¾ø´Â ¹Ì¼¼ °áÁ¤ Ç¥¸é.
  • bony external auditory canal
    ¿ÜÀ̵µÀÇ »ÀºÎºÐ , °ñ¿ÜÀ̵µ, °ñ¼º ¿ÜÀ̵µ
  • buffy layer
    ¿¬Ãþ
  • canal of foreign body of the external ear
    ¿ÜÀ̵µ À̹°
  • cartilagenous external acoustic meatus
    ¿¬°ñ ¿ÜÀ̵µ, ¿¬°ñ¼º ¿ÜÀ̵µ
  • cartilaginous external acoustic meatus
    ¿¬°ñ ¹Ù±ù ±Í±æ, ¿¬°ñ¼º ¿ÜÀ̵µ
  • cellular layer
    ¼¼Æ÷ Ãþ
    ¼¼Æ÷°¡ °ÅÀÇ ÀÏÁ¤ÇÑ µÎ²²ÀÇ, ȬÀ̺Ҹð¾çÀÇ Á¶Á÷ ±¸Á¶¸¦ °¡Áö´Â °Í.
  • cellular proliferative layer
    ¼¼Æ÷¼º Áõ½ÄÃþ
    ¼¼Æ÷ÀÇ µ¿ÀÏÇüÅÂÀÇ Àç»ý»ê ¶Ç´Â Áõ½ÄÃþ.
  • choroid layer
    ¸Æ¶ô¸· Ãþ
    Ç÷°üÀ» °¡Áø ¾È±¸ÀÇ Ãþ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
molecular pathology The study of biochemical and biophysical cellular mechanisms as the basic factors in disease.
(05 Mar 2000)
molecular probes A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in molecular genetics to detect the presence of a complementary sequence by molecular hybridization.
(12 Dec 1998)
molecular probe techniques The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms.
(12 Dec 1998)
molecular sequence data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as genbank, european molecular biology laboratory (embl), national biomedical research foundation (nbrf), or other sequence repositories.
(12 Dec 1998)
molecular sieve A gel-like material with pore sizes of such ranges as to exclude molecules above certain sizes; used in fractionating or purifying macromolecules.
(05 Mar 2000)
molecular structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number and location of chemical bonds.
(12 Dec 1998)
molecular weight The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
molecular weight ratio The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
heparin, low-molecular-weight <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Pharmacological action: anticoagulant, fibrinolytic agent.
(12 Dec 1998)
directed molecular evolution Techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter.
(12 Dec 1998)
epidemiology, molecular The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
(12 Dec 1998)
european molecular biology lab gene bank <molecular biology> A large database of DNA sequence data in Heidelberg, Germany, compiled from international sources. It is the European equivalent to the Genbank DNA sequence databank in the United States of America.
WWW: EMbase.
(09 Oct 1997)
evolution, molecular Evolution at the molecular level of DNA sequences and proteins. (rieger et al., glossary of genetics: classical and molecular, 5th ed)
(12 Dec 1998)
kinetic molecular theory <chemistry> This theory assumes that molecules must collide in order to react. The more collisions the more likely it is for a reaction to occur.
However, depending on the conditions, only a small fraction of the collisions are effective in producing a reaction. There are several constraints. In order for a reaction to occur, bonds initially are broken, which requires energy. This energy depends on the type of the reaction and comes from the kinetic energies that the molecules possess before the collision. It is called the activation energy. Increasing the temperature increases the kinetic energies and more collisions will occur. In adition, at a higher temperature a greater number of the reacting molecules might possess an energy equal to or greater than the activation energy. However the molecules must also collide in a specific orientation, called the steric factor in order for a reaction to occur.
A reaction will only be successful, if the collision has enough energy to be either equal to or greater than the activation energy and if the orientation of the collision allows for correct bond formation. These factors are in the Arrhenius equation: k = zp The rate constant k is proportional to the Arrhenius factor A. A is the product of the collision frequency z, and the steric factor p. The fraction of collisions with sufficient energy to produce a reaction are in the term of the equation.
(09 Jan 1998)
kininogen, high-molecular-weight A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with prekallikrein. Hmwk is split by plasma kallikrein to produce bradykinin. The complex is a cofactor in the activation of coagulation factor xii. The product of this reaction, xiia, in turn activates prekallikrein to kallikrein.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • layer
    ³õ´Â »ç¶÷;Ãþ
  • layer cake
    ÄÑ »çÀÌ¿¡ Å©¸² µûÀ§¸¦ ³ÖÀº °úÀÚ
  • mine layer
    ±â·Ú ºÎ¼³ÇÔ
  • nepheloid layer
    (Á¡Åä ±¸¼º¹° Å©±âÀÇ ¹Ì¼¼ÇÑ ±¤¹°ÀÌ ¶°´Ù´Ï´Â ½ÉÇØÀÇ)ÇöŹÃþ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á